Experimental factors and determinants of the protein binding of enoximone (a new cardiotonic agent) were investigated in human serum from healthy, drug-free subjects using a rapid ultrafiltration method; these factors and determinants included nonspecific binding to the apparatus, ultrafiltrate volu
β¦ LIBER β¦
Protein binding of ketamine and its active metabolites to human serum
β Scribed by Youssef Hijazi; Roselyne Boulieu
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 77 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Human serum and plasma protein binding o
β
Robert H. Hook; Harold Boxenbaum; Gary A. Thompson; Richard A. Okerholm
π
Article
π
1988
π
John Wiley and Sons
π
English
β 752 KB
Serum protein binding of tolterodine and
β
Ingrid PΓ₯hlman; Peter Gozzi
π
Article
π
1999
π
John Wiley and Sons
π
English
β 151 KB
π 2 views
The aim of this study was to determine in vitro protein binding of tolterodine and its 5-hydroxymethyl (5-HM) and N-dealkylated metabolites in serum from humans and several animal species at concentrations similar to those obtained in clinical and preclinical studies. Binding of tolterodine and the
Binding of drugs to human serum albumin
β
Ingvar SjΓΆholm; Brita Stjerna
π
Article
π
1981
π
John Wiley and Sons
π
English
β 223 KB
The binding of ketamine to plasma protei
β
P. G. Dayton; R. L. Stiller; D. R. Cook; J. M. Perel
π
Article
π
1983
π
Springer
π
English
β 689 KB
Binding of aminoglycoside antibiotics to
β
H. Rosenkranz; W. Scholtan; M. Scheer
π
Article
π
1978
π
Springer-Verlag
π
English
β 984 KB
Binding of 5,5-diphenylhydantoin and its
β
Gordon J. Conard; Coryce O. Haavik; Kenneth F. Finger
π
Article
π
1971
π
John Wiley and Sons
π
English
β 602 KB